Empowered Funds, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Empowered Funds, LLC
- $6.17 Billion
- Q3 2024
A detailed history of Empowered Funds, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Empowered Funds, LLC holds 7,064 shares of ALNY stock, worth $1.82 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
7,064
Previous 1,702
315.04%
Holding current value
$1.82 Million
Previous $413,000
370.46%
% of portfolio
0.03%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ALNY
# of Institutions
639Shares Held
108MCall Options Held
1.15MPut Options Held
1.07M-
Capital World Investors Los Angeles, CA16.5MShares$4.26 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$3.26 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.46 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.35 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.28 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $31.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...